respectively. The order parameter S at the surface of the phospholipid bilayer was significantly lowered only after 2 h ischaemia. This change in membrane fluidity onset only after 2 h ischaemia could result from the lower cholesterol/ phospholipid molar ratio and perhaps from the reduced content in phosphatidylserine. This change of fluidity, occurring only after 2 h ischaemia, could induce a significant change in permeability of the plasma membrane which set in after the point of irreversible cellular alteration.
I .

2.
3. The peptide neurotransmitter cholecystokinin (CCK) is widely distributed in the central nervous system (CNS) and is thought to be involved in a variety of centrally mediated behaviours. Of particular interest is the suggestion that opioid and CCK systems interact in an antagonistic manner to influence behaviours including antinociception (Faris, 1985) . Neurochemical studies show a similar interaction.
Goldbarg
Opiates are reported to inhibit CCK release from hypothalamic slices in vitro (Miceyvich et a[., 1982 (Miceyvich et a[., , 1984 and CCK levels in hypothalamus are elevated after morphine injection (Faris et al., 1986) . Sirnilarb we have shown that the release of CCK from slices of a brain region involved in pain control, the periaqueductal grey (PAG) is modulated by opiates (Rattray & de Belleroche, 1986a , 1987 . Our results imply that opiates have an inhibitory effect on CCK release from PAG which, in this tissue, is masked unless the tissue is naloxone pretreated. In the present study, the time dependence of the effects of morphine on PAG CCK release was studied.
Male CFY rats (250-350 g) were killed and their brains removed. The PAG were dissected out and chopped into slices of 0.3 mm thickness. Slices were incubated at 37°C in Krebs/bicarbonate medium containing 0.5 mM-bacitracin and gassed with 95% 0 , / 5 % CO,. After a preincubation period of 15-60 min in the presence or absence of lo-' Mmorphine, the slices were transferred to fresh medium without morphine for 10 min to evaluate basal CCK release. Finally, the slices were transferred into fresh control medium with an elevated K+ concentration (34 mM) and incubated for 5 min to evoke neurotransmitter release. Supernatants were centrifuged to remove tissue fragments and stored at -20°C until assay. The tissue slices after incubation were placed in vials containing 90% methanol and sonicated to (Fig. 1) . The greatest effect (7 1 k 36% increase, n = 7, P < 0.05) was observed after 30 min morphine preincubation. At 45 or 6 0 min preincubation, morphine-induced increases in CCK release were apparent, but not significant ( P < 0.10).
The effect of prolonged morphine treatment on PAG CCK release is strikingly different from the morphineinduced inhibition of PAG CCK release, observed over a shorter exposure time (Rattray & de Belleroche, 1987) . The When PAG slices were exposed to morphine ( increases observed on PAG CCK release in vitro compare with observed increases in CCK octapeptide and CCK mRNA levels which occur in PAG after morphine injection (Rattray & de Belleroche, 19866) . This suggests that CCK synthesis and release are coupled and that morphine may exert these delayed effects by a post-receptor action modulating protein synthesis.
We are grateful to the S.E.R.C. and Glaxo Group Research for a C.A.S.E. studentship for this work. The sarcolemmal Na-Ca exchange system is an important component of the mechanism whereby changes in intracellular Na concentration are translated into changes in developed tension in mammalian cardiac tissue. It might have an important role in bringing about the final physiological response, since intracellular organelles, especially the sarcoplasmic reticulum, participate directly in regulating the intracellular Ca concentration Chapmann & Rodrigo, 1983; Reeves, 1984) . It is obvious, therefore, that a direct correlation between sarcolemmal Na-Ca exchange activity and physiological processes is somewhat difficult to obtain. In this respect, the utilization of a cardioactive agent, which also inhibits the Na-Ca exchanger, would be an advantage. Agents such as quinacrine and amiloride (Sutko et Slaughter et al., 1984) and verapamil (Erdreich et al., 1983), were found to inhibit the Na-Ca exchanger. However, none of these agents seem to be an appropriate tool, since the effect did not parallel their response in vivo. Harmaline, which was found to have a series of cardiovascular actions (Zetler, 1974; Carpentier & Narvarte, 1975; Carpentier & Diaz, 1977; Aarons et al., 1977; Carpentier, 1980) , was also found to inhibit the Na-Ca exchange mechanism in ileal smooth muscles (Suleiman, 1985; Suleiman & Hider, 1985) and in cardiac sarcolemma1 vesicles (Suleiman & Reeves, 1987) . In the case of the latter, harmaline was found to be a competitive inhibitor with respect to Ca ( K , = 2.5 x l o d 4 M). Furthermore, in preparations both in vitro and in vivo , the inhibitory potency demonstrated by harmaline was similar. This finding is significant and provides a tool necessary for the elucidation of the contribution of the Na-Ca exchanger in the physiological activities of cardiac muscle.
